In This Section

AACR Grantees Share their Findings

We are extremely proud of our past and present grantees who published their findings this past year on their work that has been made possible through the support of the AACR and its funding partners.

January

Novel therapeutic strategy for uveal melanoma

Dual anti-cancer and anti-cachexia benefits of targeting PERP in pancreatic cancer

February

Insights into and implications of HER3 structure

March

Viral immunotherapy for osteosarcoma

Velez et al., 2022. Mol Cancer Ther. 2022;21(3):471-480. doi:10.1158/1535-7163.MCT-21-0565

March-July

Optimizing next-generation technologies to gain novel insights

July

Novel target to mitigate chemobrain

Role of environmental context on pancreatic cancer metabolism

Mechanisms of efficacy of Tumor treating fields in mesothelioma

August

Molecular insights on Richter transformation

Next-generation genetic tool to elucidate DNA-protein interactions

September

Potential strategy to block osteosarcoma metastasis

Novel biomarker of disease progression

September-October

Interrogating the Impact of Tumor treating fields

October

Third generation therapeutic for rhabdomyosarcoma

Potential biomarkers of recurrence

December

Cancer health disparities in head and neck cancer